NCT00380302 Activity of AVE1625 in Mild to Moderate Alzheimer's Patients. Status COMPLETED Phase PHASE1/PHASE2
NCT00379717 Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) Status UNKNOWN Phase PHASE1/PHASE2
NCT00378573 Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00377780 Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT00377559 Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00377273 An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses Status COMPLETED Phase PHASE4
NCT00377000 A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels. Status COMPLETED Phase PHASE4
NCT00374166 An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder Status COMPLETED Phase PHASE2
NCT00372216 CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction Status COMPLETED Phase PHASE3
NCT00370565 Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy. Status COMPLETED Phase PHASE3
NCT00370162 Acceptability Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene Status COMPLETED Phase PHASE3
NCT00368797 Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease Status COMPLETED Phase PHASE2
NCT00366795 Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver Status TERMINATED Phase PHASE3
NCT00366301 The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes Status TERMINATED Phase PHASE4
NCT00365365 Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer Status COMPLETED Phase PHASE2
NCT00364611 Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2